Skip to main content
Top
Published in: Internal and Emergency Medicine 8/2022

15-08-2022 | SARS-CoV-2 | IM - ORIGINAL

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study

Authors: Deborah Blanca, Selene Nicolosi, Alessandra Bandera, Francesco Blasi, Marco Mantero, Cinzia Hu, Margherita Migone de Amicis, Tiziano Lucchi, Giuseppina Schinco, Flora Peyvandi, Roberta Gualtierotti, Anna Ludovica Fracanzani, Rosa Lombardi, Ciro Canetta, Nicola Montano, Lorenzo Beretta, on behalf of the Covid Network

Published in: Internal and Emergency Medicine | Issue 8/2022

Login to get access

Abstract

COVID-19 spread in two pandemic waves in Italy between 2020 and 2021. The aim of this study is to compare the first with the second COVID-19 wave, analyzing modifiable and non-modifiable factors and how these factors affected mortality in patients hospitalized in Internal Medicine wards. Consecutive patients with SARS-CoV-2 infection and dyspnea requiring O2 supplementation were included. The severity of lung involvement was categorized according to the patients’ oxygen need. Six hundred and ten SARS-CoV-2 hospitalized patients satisfied the inclusion criteria. The overall estimated 4-week mortality was similar in the two pandemic waves. Several variables were associated with mortality after univariate analysis, but they lacked the significance after multivariable adjustment. Steroids did not exert any protective effect when analyzed in time-dependent models in the whole sample; however, steroids seemed to exert a protective effect in more severe patients. When analyzing the progression to different states of O2 supplementation during hospital stay, mortality was almost exclusively associated with the use of high-flow O2 or CPAP. The analysis of the transition from one state to the other by Cox–Markov models confirmed that age and the severity of lung involvement at admission, along with fever, were relevant factor for mortality or progression.
Appendix
Available only for authorised users
Literature
1.
go back to reference World Health Organization, Mission China Joint (2020) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO-China Jt Mission Coronavirus Dis 2019. 2019. World Health Organization, Mission China Joint (2020) Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO-China Jt Mission Coronavirus Dis 2019. 2019.
2.
go back to reference WHO COVID-19 global table data May 5th 2021 at 10 WHO COVID-19 global table data May 5th 2021 at 10
5.
12.
go back to reference Shrestha DB, Budhathoki P, Syed N-I-H et al (2021) Remdesivir: a potential game-changer or just a myth? A systematic review and meta-analysis. Life Sci 264:118663CrossRefPubMed Shrestha DB, Budhathoki P, Syed N-I-H et al (2021) Remdesivir: a potential game-changer or just a myth? A systematic review and meta-analysis. Life Sci 264:118663CrossRefPubMed
18.
19.
22.
go back to reference Ghosn L, Chaimani A, Evrenoglou T, Davidson M, Graña C, Schmucker C, Bollig C, Henschke N, Sguassero Y, Nejstgaard CH, Menon S, Nguyen TV, Ferrand G, Kapp P, Riveros C, Ávila C, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P BI (2021) Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. https://doi.org/10.1002/14651858.CD013881.www.cochranelibrary.com Ghosn L, Chaimani A, Evrenoglou T, Davidson M, Graña C, Schmucker C, Bollig C, Henschke N, Sguassero Y, Nejstgaard CH, Menon S, Nguyen TV, Ferrand G, Kapp P, Riveros C, Ávila C, Devane D, Meerpohl JJ, Rada G, Hróbjartsson A, Grasselli G, Tovey D, Ravaud P BI (2021) Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. https://​doi.​org/​10.​1002/​14651858.​CD013881.​www.​cochranelibrary.​com
23.
go back to reference Sadeghipour P, Talasaz AH, Rashidi F et al (2021) Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinic. JAMA J Am Med Assoc 325:1620–1630. https://doi.org/10.1001/jama.2021.4152CrossRef Sadeghipour P, Talasaz AH, Rashidi F et al (2021) Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinic. JAMA J Am Med Assoc 325:1620–1630. https://​doi.​org/​10.​1001/​jama.​2021.​4152CrossRef
30.
go back to reference R Core Team. (2017) R: A language and environment for statistical computing. In: R Found Stat Comput. Vienna, Austria R Core Team. (2017) R: A language and environment for statistical computing. In: R Found Stat Comput. Vienna, Austria
Metadata
Title
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study
Authors
Deborah Blanca
Selene Nicolosi
Alessandra Bandera
Francesco Blasi
Marco Mantero
Cinzia Hu
Margherita Migone de Amicis
Tiziano Lucchi
Giuseppina Schinco
Flora Peyvandi
Roberta Gualtierotti
Anna Ludovica Fracanzani
Rosa Lombardi
Ciro Canetta
Nicola Montano
Lorenzo Beretta
on behalf of the Covid Network
Publication date
15-08-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 8/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03052-3

Other articles of this Issue 8/2022

Internal and Emergency Medicine 8/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.